Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV studyAnne Marie W. Efsen, Brygida Knysz, Hansjakob Furrer et al.|Journal of Infection|2017Cited by 41
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHEREAndrew Atkinson, Luis Prieto, Marcel Zwahlen et al.|Clinical Infectious Diseases|2020Cited by 21
No need for secondary <i>Pneumocystis jirovecii</i> pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Hansjakob Furrer, José M. Miró et al.|Journal of the International AIDS Society|2021Cited by 17
Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin AmericaYanink Caro‐Vega, Brenda Crabtree‐Ramírez, Anna Schultze et al.|BMC Infectious Diseases|2018Cited by 12